BSE Live
Apr 13, 16:00Prev. Close
20.48
Open Price
20.48
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Brawn Biotech (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | |
| Total Share Capital | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | |
| Reserves and Surplus | 6.26 | 5.66 | 4.63 | 3.92 | 2.53 | |
| Total Reserves and Surplus | 6.26 | 5.66 | 4.63 | 3.92 | 2.53 | |
| Total Shareholders Funds | 9.26 | 8.66 | 7.63 | 6.92 | 5.53 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.01 | 0.01 | 0.03 | 0.00 | 0.00 | |
| Long Term Provisions | 0.10 | 0.15 | 0.17 | 0.10 | 0.08 | |
| Total Non-Current Liabilities | 0.11 | 0.16 | 0.20 | 0.10 | 0.13 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 8.59 | 10.35 | 11.23 | 6.82 | 4.95 | |
| Other Current Liabilities | 2.16 | 3.21 | 3.07 | 2.81 | 1.75 | |
| Short Term Provisions | 0.18 | 0.14 | 0.44 | 0.39 | 1.59 | |
| Total Current Liabilities | 10.92 | 13.70 | 14.74 | 10.01 | 8.30 | |
| Total Capital And Liabilities | 20.29 | 22.52 | 22.57 | 17.03 | 13.95 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 0.18 | 0.19 | 0.22 | 0.25 | 0.24 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 0.18 | 0.19 | 0.22 | 0.25 | 0.24 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | |
| Deferred Tax Assets [Net] | 0.07 | 0.06 | 0.08 | 0.05 | 0.02 | |
| Long Term Loans And Advances | 0.00 | 0.05 | 0.03 | 0.11 | 0.08 | |
| Other Non-Current Assets | 0.83 | 0.47 | 0.48 | 0.00 | 2.68 | |
| Total Non-Current Assets | 1.08 | 0.77 | 0.81 | 0.40 | 3.05 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 0.39 | 0.34 | 0.35 | 0.37 | 0.50 | |
| Trade Receivables | 15.00 | 16.46 | 15.05 | 13.02 | 9.20 | |
| Cash And Cash Equivalents | 0.40 | 0.54 | 0.40 | 2.00 | 0.17 | |
| Short Term Loans And Advances | 0.01 | 0.00 | 0.00 | 0.00 | 1.03 | |
| OtherCurrentAssets | 3.41 | 4.41 | 5.96 | 1.23 | 0.00 | |
| Total Current Assets | 19.21 | 21.75 | 21.76 | 16.63 | 10.90 | |
| Total Assets | 20.29 | 22.52 | 22.57 | 17.03 | 13.95 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 44.92 | 61.28 | 51.24 | 54.76 | 39.96 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | 0.03 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
24.11.2025
Brawn Pharma Standalone September 2025 Net Sales at Rs 4.89 crore, up 48.36% Y-o-Y
28.05.2025
Brawn Pharma Standalone March 2025 Net Sales at Rs 2.26 crore, down 34.45% Y-o-Y
17.02.2025
Brawn Pharma Standalone December 2024 Net Sales at Rs 3.84 crore, up 35.25% Y-o-Y
25.11.2024
Brawn Pharma Standalone September 2024 Net Sales at Rs 3.30 crore, up 12.95% Y-o-Y
24.11.2025
Brawn Pharma Standalone September 2025 Net Sales at Rs 4.89 crore, up 48.36% Y-o-Y
28.05.2025
Brawn Pharma Standalone March 2025 Net Sales at Rs 2.26 crore, down 34.45% Y-o-Y
17.02.2025
Brawn Pharma Standalone December 2024 Net Sales at Rs 3.84 crore, up 35.25% Y-o-Y
25.11.2024
Brawn Pharma Standalone September 2024 Net Sales at Rs 3.30 crore, up 12.95% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth